Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Hepatology
Volume 2015, Article ID 573513, 4 pages
http://dx.doi.org/10.1155/2015/573513
Case Report

Hepatorenal Syndrome with Cirrhotic Cardiomyopathy: Case Report and Literature Review

1Department of Internal Medicine, Hospital Universitário Antônio Pedro (HUAP), Universidade Federal Fluminense (UFF), Rua Marquês de Paraná 303, 7° Andar, Centro, 24033-900 Niterói, RJ, Brazil
2Department of Echocardiography, Hospital Universitário Antônio Pedro (HUAP), Universidade Federal Fluminense (UFF), Rua Marquês de Paraná 303, 7° Andar, Centro, 24033-900 Niterói, RJ, Brazil
3Department of Cardiology, Hospital Universitário Antônio Pedro (HUAP), Universidade Federal Fluminense (UFF), Rua Marquês de Paraná 303, 7° Andar, Centro, 24033-900 Niterói, RJ, Brazil

Received 10 December 2014; Accepted 12 March 2015

Academic Editor: Melanie Deutsch

Copyright © 2015 Luis Mocarzel et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Bonder, M. L. Botero, and A. Cardenas, “Current therapies for hepatorenal syndrome,” Current Hepatitis Reports, vol. 13, no. 1, pp. 74–80, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Wiese, J. D. Hove, F. Bendtsen, and S. Møller, “Cirrhotic cardiomyopathy: pathogenesis and clinical relevance,” Nature Reviews Gastroenterology & Hepatology, vol. 11, no. 3, pp. 177–186, 2013. View at Publisher · View at Google Scholar
  3. V. Arroyo, P. Ginès, A. L. Gerbes et al., “Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis,” Hepatology, vol. 23, no. 1, pp. 164–176, 1996. View at Publisher · View at Google Scholar · View at Scopus
  4. E. M. Zardi, A. Abbate, D. M. Zardi et al., “Cirrhotic cardiomyopathy,” Journal of the American College of Cardiology, vol. 56, no. 7, pp. 539–549, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Páll, A. Czifra, Z. Vitális, M. Papp, G. Paragh, and Z. Szabó, “Pathophysiological and clinical approach to cirrhotic cardiomyopathy,” Journal of Gastrointestinal and Liver Diseases, vol. 23, no. 3, pp. 301–310, 2014. View at Publisher · View at Google Scholar
  6. H. J. Kowalski and W. H. Abelmann, “The cardiac output at rest in Laennec's cirrhosis,” The Journal of Clinical Investigation, vol. 32, no. 10, pp. 1025–1033, 1953. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Chayanupatkul and S. Liangpunsakul, “Cirrhotic cardiomyopathy: review of pathophysiology and treatment,” Hepatology International, vol. 8, no. 3, pp. 308–315, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Møller and M. Bernardi, “Interactions of the heart and the liver,” European Heart Journal, vol. 34, no. 36, pp. 2804–2811, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Møller and J. H. Henriksen, “Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver disease,” Heart, vol. 87, no. 1, pp. 9–15, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Møller and J. H. Henriksen, “Cardiovascular complications of cirrhosis,” Gut, vol. 57, no. 2, pp. 268–278, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. V. Arroyo, R. García-Martinez, and X. Salvatella, “Human serum albumin, systemic inflammation and cirrhosis,” Journal of Hepatology, vol. 61, no. 2, pp. 396–407, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Páll, A. Czifra, Z. Vitális, M. Papp, G. Paragh, and Z. Szabó, “Pathophysiological and clinical approach to cirrhotic cardiomyopathy,” Journal of Gastrointestinal and Liver Diseases, vol. 23, no. 3, pp. 301–310, 2014. View at Google Scholar
  13. S. Møller, J. D. Hove, U. Dixen, and F. Bendtsen, “New insights into cirrhotic cardiomyopathy,” International Journal of Cardiology, vol. 167, no. 4, pp. 1101–1108, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. Iwanaga, I. Nishi, S. Furuichi et al., “B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: Comparison between systolic and diastolic heart failure,” Journal of the American College of Cardiology, vol. 47, no. 4, pp. 742–748, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Padillo, P. Rioja, M. C. Muñoz-Villanueva et al., “BNP as marker of heart dysfunction in patients with liver cirrhosis,” European Journal of Gastroenterology and Hepatology, vol. 22, no. 11, pp. 1331–1336, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. V. G. Mota and B. M. Filho, “EcoDopplercardiografia na Doença Hepática Crônica: Revisão Sistemática,” Arquivos Brasileiros de Cardiologia, vol. 100, no. 4, pp. e376–e385, 2013. View at Google Scholar
  17. K. Kazankov, P. Holland-Fischer, N. H. Andersen et al., “Resting myocardial dysfunction in cirrhosis quantified by tissue Doppler imaging,” Liver International, vol. 31, no. 4, pp. 534–540, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. W. C. Yancy, M. Jessup, B. Bozkurt et al., “Guideline for the management of heart failure,” Circulation, vol. 128, pp. e240–e327, 2013. View at Publisher · View at Google Scholar
  19. C. Caramelo, D. Fernandez-Munoz, J. C. Santos et al., “Effect of volume expansion on hemodynamics, capillary permeability and renal function in conscious, cirrhotic rats,” Hepatology, vol. 6, no. 1, pp. 129–134, 1986. View at Publisher · View at Google Scholar · View at Scopus
  20. E. Mikulic, C. Muñoz, L. E. Puntoni, and D. Lebrec, “Hemodynamic effects of dobutamine in patients with alcoholic cirrhosis,” Clinical Pharmacology & Therapeutics, vol. 34, no. 1, pp. 56–59, 1983. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Y. Kim, S. K. Baik, C. S. Won et al., “Dobutamine stress echocardiography for evaluating cirrhotic cardiomyopathy in liver cirrhosis,” The Korean Journal of Hepatology, vol. 16, no. 4, pp. 376–382, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Nodari and A. Palazzuoli, “Current treatment in acute and chronic cardio-renal syndrome,” Heart Failure Reviews, vol. 16, no. 6, pp. 583–594, 2011. View at Publisher · View at Google Scholar · View at Scopus